Surgery in patients with congenital factor VII deficiency: A single center experience

BACKGROUND: Congenital factor VII (FVII) deficiency is a rare hemorrhagic disorder that can cause excessive bleeding during and after surgery in affected patients. The recombinant form of activated factor VII (rFVIIa, NovoSeven® from Novo Nordisk, Bagsvaerd, Denmark), which was developed as a second...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Shin-Hee, Park, Young Shil, Kwon, Kee-Hwan, Lee, Jae Hoon, Kim, Kwang Chul, Yoo, Myung Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538800/
https://www.ncbi.nlm.nih.gov/pubmed/23320007
http://dx.doi.org/10.5045/kjh.2012.47.4.281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538800/
https://www.ncbi.nlm.nih.gov/pubmed/23320007
http://dx.doi.org/10.5045/kjh.2012.47.4.281

Ejemplares similares